UNICREDIT BANK/CALL/BIOGEN IDEC/450/0.1/18.06.25 Share Price

Warrant

DE000HC96FD7

Real-time BOERSE MUENCHEN 20:42:00 20/05/2024 BST
0.35 EUR +16.67% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/450/0.1/18.06.25
Current month+169.23%
1 month+400.00%
Date Price Change
20/05/24 0.35 +16.67%
17/05/24 0.3 -3.23%
16/05/24 0.31 0.00%
15/05/24 0.31 +34.78%
14/05/24 0.23 +4.55%

Real-time BOERSE MUENCHEN

Last update May 20, 2024 at 08:42 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC96FD
ISINDE000HC96FD7
Date issued 11/09/2023
Strike 450 $
Maturity 18/06/2025 (394 Days)
Parity 10 : 1
Emission price 1.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.35
Lowest since issue 0.001
Delta0.11x
Omega 5.870
Premium96.37x
Gearing55.32x
Moneyness 0.5140
Difference Strike 218.4 $
Difference Strike %+48.54%
Spread 0.05
Spread %12.20%
Theoretical value 0.3850
Implied Volatility 40.33 %
Total Loss Probability 95.22 %
Intrinsic value 0.000000
Present value 0.3850
Break even 454.18 €
Theta-0.02x
Vega0.04x
Rho0.02x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.6 USD
Average target price
285.9 USD
Spread / Average Target
+23.47%
Consensus